Clinical Trials · NCT00001228

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer

Name: Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Octreotide

Phase: Phase 2
Recruitment status: Completed
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrollment: 50
Start date: Oct 1988
Locations: 1 site, United States
Primary endpoint: Study in Islet Cell Adenoma

View Octreotide compound reference